Finoriq research workspace
AtriCure, Inc. (ATRC) SEC Filings & Filing Highlights
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation. Review ATRC SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatment of cardiac arrhythmias; cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; and EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation. It also provides cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; cryoXT probes, a cryoablation device designed specifically for Cryo Nerve Block therapy; LARIAT System, a solution for soft-tissue closure; Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; and Subtle Cannula's to support access for EPi-Sense catheters. In addition, the company sells various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
- Company
- AtriCure, Inc. (ATRC)
- Ticker
- ATRC
- Market Cap
- $1.8B
- Latest Price
- $34.87
- Industry
- Medical Devices
AtriCure, Inc. (ATRC) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for AtriCure, Inc. (ATRC).
| Event | Form | Date |
|---|---|---|
| The stockholders of the Company voted on the following proposals at the Annual MeetingThe stockholders of the Company voted on the following proposals at the Annual Meeting | 8-K5.07 | 2026-05-19 |
| At the AtriCure, Inc. (the “Company”) 2026 Annual Meeting of Stockholders held on May 18, 2026...At the AtriCure, Inc. (the “Company”) 2026 Annual Meeting of Stockholders held on May 18, 2026 (“Annual Meeting”), the stockholders of the... | 8-K5.02 | 2026-05-19 |
| AtriCure Reports First Quarter 2026 Financial ResultsAtriCure Reports First Quarter 2026 Financial Results | 8-K2.02 | 2026-05-05 |
| AtriCure, Inc.: Earnings or resultsOn February 17, 2026, AtriCure, Inc. issued a press release regarding its financial results for the fourth quarter and full-year ended Dece... | 8-K2.02 | 2026-02-17 |
| Debt or FinancingDebt or Financing | 8-K2.03 | 2026-01-12 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.